Internet | Biotech Stock Review | News On Internet and Biotech Stocks. | Page 38

Contact Us

Contact Us.

Editor / Curator - December 15, 2015

Uncategorized

Disclaimer

Editor / Curator - December 15, 2015

Roland Rick Perry, Biotech Stock Review

Biotech News

CNS Wellness, Leading Brain Research and Treatment Technology Company Hits Ground...

Editor / Curator - September 2, 2015

Video

Zestra® Female Sexual Arousal on ABC’s “The View.”

Editor / Curator - August 20, 2013

zestra, biotech stock review

eCommerce

Innovus (INNV) Zestra® Female Sexual Arousal Oils Featured in NY Times.

Editor / Curator - July 2, 2012

Biotech Stock Review

Health $ Fitness

Christopher E. Rivera Appointed to the Council of Washington Biotechnology &...

Editor / Curator - June 27, 2011

All News

Adding VirnetX (VHC) $6.50 To Watch List.

Editor / Curator - June 10, 2010

Research

Circle Group / Z-Trim (CRGQ/ZTRM) $2.50. Report.

Editor / Curator - September 3, 2003

Research

Circle Group Holdings (CRGQ) $0.47 Report.

Editor / Curator - March 19, 2003

Internet Stock Review

Research

Adding the Jackson Family’s Modern Records (MDNR) to Watch List.

Editor / Curator - December 13, 2000

1...373839 Page 38 of 39

Latest article

Mitesco, Biotech Stock Review, roland rick perry

Short Squeeze Mania.

Uncategorized Editor / Curator - January 26, 2021

Short Squeeze Mania Game Stop (GME) up 7,850%, in one year.National Beverage (FIZZ) up 86% in one week, 288%...

Video: Pacific Stem Cell

Stem Cells Editor / Curator - January 24, 2021

With nearly a third of the US suffering from chronic pain, and over a million patients a year having joint replacements, affordable...

ENDRA, Biotech Stock Review

Heads UP: ENDRA Life Science (NDRA) $1.50, up 40% Today.

Biotech News Editor / Curator - January 19, 2021

Are Expectations of a 501K Approval Perking Up? We've learned through trial and error (with the better...

The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062